Antidepressant-like behavioral, neurochemical and neuroendocrine effects of naringenin in the mouse repeated tail suspension test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 39, Issue 1, 2012, Pages 175-181

  Yi, Li Tao ^a   Li, Jing ^a   Li, Huo Chen ^a   Su, Dong Xue ^a   Quan, Xia Bo ^a   He, Xiao Cheng ^a   Wang, Xiao Hong ^a  

^a HUAQIAO UNIVERSITY   (China)

Author keywords

Antidepressant; Corticosterone; Glucocorticoid receptor; Naringenin; Neurotransmitters

Indexed keywords

CORTICOSTERONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; NARINGENIN; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SCREENING; EXPERIMENTAL TEST; IMMOBILIZATION; MALE; MOUSE; NEUROCHEMISTRY; NEUROENDOCRINE SYSTEM; NONHUMAN; NORADRENALIN BRAIN LEVEL; SEROTONIN BRAIN LEVEL; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; CORTICOSTERONE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; HINDLIMB SUSPENSION; HIPPOCAMPUS; IMMOBILITY RESPONSE, TONIC; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; NOREPINEPHRINE; RECEPTORS, GLUCOCORTICOID; SEROTONIN;

EID: 84864496275     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.06.009     Document Type: Article

References (45)

1. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004, 29:185-193.
2. Barton D.A., Esler M.D., Dawood T., Lambert E.A., Haikerwal D., Brenchley C., et al. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry 2008, 65:38-46.
3. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7:137-151.
4. Bowden C., Cheetham S.C., Lowther S., Katona C.L., Crompton M.R., Horton R.W. Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 1997, 769:135-140.
5. Clark J.A., Flick R.B., Pai L.Y., Szalayova I., Key S., Conley R.K., et al. Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice. Mol Psychiatry 2008, 13:498-506.
6. Cryan J.F., Page M.E., Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 2005, 182:335-344.
7. Delgado P.L. Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000, 61(Suppl. 6):7-11.
8. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 1997, 5:107-112.
9. Doczy E.J., Seroogy K., Harrison C.R., Herman J.P. Hypothalamo-pituitary-adrenocortical axis, glucocorticoids, and neurologic disease. Immunol Allergy Clin North Am 2009, 29:265-284.
10. Elhwuegi A.S. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:435-451.
11. Espallergues J., Mamiya T., Vallée M., Koseki T., Nabeshima T., Temsamani J., et al. The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels. Neuropharmacology 2012, 62:492-502.
12. Gillman P.K. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 2007, 151:737-748.
13. Gutiérrez-García A.G., Contreras C.M. Stressors can affect immobility time and response to imipramine in the rat forced swim test. Pharmacol Biochem Behav 2009, 91:542-548.
14. Haider S., Khaliq S., Haleem D.J. Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. Pharmacol Rep 2007, 59:53-57.
15. Heydendael W., Jacobson L. Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression. Brain Res 2009, 1288:69-78.
16. Hsu L.C., Ko Y.J., Cheng H.Y., Chang C.W., Lin Y.C., Cheng Y.H., et al. Antidepressant-like activity of the ethanolic extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the forced swimming test and in the tail suspension test in mice. Evid Based Complement Altern Med 2012, 497302.
17. Idayu N.F., Hidayat M.T., Moklas M.A., Sharida F., Raudzah A.R., Shamima A.R., et al. Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine 2011, 18:402-407.
18. Juruena M.F., Cleare A.J., Pariante C.M. The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression. Rev Bras Psiquiatr 2004, 26:189-201.
19. Kirby L.G., Chou-Green J.M., Davis K., Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 1997, 760:218-230.
20. Lanfumey L., Mongeau R., Cohen-Salmon C., Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 2008, 32:1174-1184.
21. Li S.X., Perry K.W., Wong D.T. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology 2002, 42:181-190.
22. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53.
23. Makino S., Smith M.A., Gold P.W. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Brain Res 2002, 943:216-223.
24. Manthey L., Leeds C., Giltay E.J., van Veen T., Vreeburg S.A., Penninx B.W., et al. Antidepressant use and salivary cortisol in depressive and anxiety disorders. Eur Neuropsychopharmacol 2011, 21:691-699.
25. Mao Q., Huang Z., Ip S., Che C. Antidepressant-like effect of ethanol extract from Paeonia lactiflora in mice. Phytother Res 2008, 22:1496-1499.
26. McEwen B.S. Glucocorticoid binding sites in rat brain: subcellular and anatomical localizations. Prog Brain Res 1973, 39:87-97.
27. Mezadri T.J., Batista G.M., Portes A.C., Marino-Neto J., Lino-de-Oliveira C. Repeated rat-forced swim test: reducing the number of animals to evaluate gradual effects of antidepressants. J Neurosci Methods 2011, 195:200-205.
28. Mizoguchi K., Ishige A., Aburada M., Tabira T. Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience 2003, 119:887-897.
29. Nakazawa T., Yasuda T., Ueda J., Ohsawa K. Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol Pharm Bull 2003, 26:474-480.
30. Nutt D., Demyttenaere K., Janka Z., Aarre T., Bourin M., Canonico P.L., et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol 2007, 21:461-471.
31. Papakostas G.I., Fava M. A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Can J Psychiatry 2006, 51:783-790.
32. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001, 49:391-404.
33. Porter R.J., Gallagher P., Watson S., Young A.H. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 2004, 173:1-17.
34. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci Biobehav Rev 2010, 35:104-114.
35. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
36. Xia X., Cheng G., Pan Y., Xia Z.H., Kong L.D. Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test. J Ethnopharmacol 2007, 110:356-363.
37. Xiang H., Liu Y., Zhang B., Huang J., Li Y., Yang B., et al. The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of Panax notoginseng in animal models of depression. Phytomedicine 2011, 18:731-738.
38. Yau J.L., Noble J., Thomas S., Kerwin R., Morgan P.E., Lightman S., et al. The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice. Neuropsychopharmacology 2007, 32:2520-2529.
39. Yi L.T., Li J.M., Li Y.C., Pan Y., Xu Q., Kong L.D. Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life Sci 2008, 82:741-751.
40. Yi L.T., Li Y.C., Pan Y., Li J.M., Xu Q., Mo S.F., et al. Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea corylifolia in the forced swimming test in mice. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:510-519.
41. Yi L.T., Xu Q., Li Y.C., Yang L., Kong L.D. Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:616-624.
42. Yi L.T., Li C.F., Zhan X., Cui C.C., Xiao F., Zhou L.P., et al. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1223-1228.
43. Zhou D., Jin H., Lin H.B., Yang X.M., Cheng Y.F., Deng F.J., et al. Antidepressant effect of the extracts from Fructus akebiae. Pharmacol Biochem Behav 2010, 94:488-495.
44. Zhou Q.G., Zhu L.J., Chen C., Wu H.Y., Luo C.X., Chang L., et al. Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor. J Neurosci 2011, 31:7579-7590.
45. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:722-729.